z-logo
Premium
Hydrophilic interaction chromatography/tandem mass spectrometry for the simultaneous determination of three polar non‐structurally related compounds, imipenem, cilastatin and an investigational β ‐lactamase inhibitor, MK‐4698, in biological matrices
Author(s) -
Xu Yang,
Xie Wei,
MillerStein Cynthia M.,
Woolf Eric J.
Publication year - 2009
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.4138
Subject(s) - chemistry , chromatography , tandem mass spectrometry , mass spectrometry , polar , physics , astronomy
A method coupling hydrophilic interaction chromatography (HILIC) with tandem mass spectrometry (MS/MS) has been developed for the simultaneous determination of three polar non‐structurally related compounds – a carbapenem antibiotic, imipenem (IMP), a renal dehydropeptidase inhibitor, cilastatin (CIL), and an investigational β ‐lactamase inhibitor, MK‐4698 (BLI), in rat plasma, monkey plasma and mouse blood. The analytes were extracted through protein precipitation, chromatographed on a Waters Atlantis HILIC column, and detected on a Sciex API4000 mass spectrometer using a Turbo‐Ion Spray ion source in positive ionization mode following multiple‐reaction monitoring (MRM). The assay dynamic range was 0.1–100 µg/mL for IMP, CIL and BLI, respectively, using a total of 20–25 µL biologic samples, and the total HPLC/MS/MS run time was 4 min/injection. The assay was found to be sensitive, selective and reproducible. The challenges, namely, sample stability, blood sample processing, matrix effect in monkey study samples, and dilution re‐assays for the limited mouse blood samples, are resolved and discussed. This technique allowed rapid analysis of polar compounds in biologic matrixes with satisfactory chromatographic retention and increased throughput. Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here